Abera Bioscience AB (NGM:ABERA)

Abera Bioscience AB Revenue

Abera Bioscience AB had revenue of 1.56M SEK in the quarter ending June 30, 2026, a decrease of -63.63%. This brings the company's revenue in the last twelve months to 9.10M, down -42.15% year-over-year. In the year 2025, Abera Bioscience AB had annual revenue of 11.85M, down -18.99%. That makes Abera Bioscience AB the 43,719th largest company in the world by revenue and 677th in Sweden.

• Revenue (ttm): 9.10M
• Revenue Growth: -42.15%
• P/S Ratio: 15.46
• Revenue / Employee: 1.52M
• Employees: 6
• Market Cap: 140.62M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	11.85M	-2.78M	-18.99%
Dec 31, 2024	14.63M	12.11M	479.60%
Dec 31, 2023	2.52M	736.19K	41.18%
Dec 31, 2022	1.79M	609.91K	51.78%
Dec 31, 2021	1.18M	422.43K	55.92%

Data Source: S&P Global Market Intelligence Last updated: Aug 20, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 5, 2026

Data Sources Report a data error